Explore more topics
SEC reporting owner

ROCHE HOLDING LTD SEC insider disclosures

Explore ROCHE HOLDING LTD's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-13T06:40:31.983Z

Reporting owner CIK
0000889131
Issuers
10
Coverage
verified
Jump to a section

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Scroll sideways to compare all columns. Select a heading to sort.

BIOVERIS CORP0001264899BIOVNoNo
Foundation Medicine, Inc.0001488613FMINoYes
Senseonics Holdings, Inc.0001616543SENSNoNo
AILERON THERAPEUTICS INC0001420565ALRNNoNo
Allakos Inc.0001564824ALLKNoNo
Spark Therapeutics, Inc.0001609351ONCENoNo
Pandion Therapeutics, Inc.0001807901PANDNoNo
Jasper Therapeutics, Inc.0001788028JSPRNoNo
Entrada Therapeutics, Inc.0001689375TRDANoNo
Aligos Therapeutics, Inc.0001799448ALGSNoNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.